Melvin H. Hayes's most recent trade in Fulcrum Therapeutics Inc was a trade of 135,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Melvin H. Hayes | Chief Operating Officer | 09 Feb 2023 | 135,000 | 135,000 | - | - | Stock Option (right to buy) | ||
| Fulcrum Therapeutics Inc | Melvin H. Hayes | Chief Operating Officer | 09 Aug 2022 | 137,000 | 137,000 | - | - | Stock Option (right to buy) |